<DOC>
	<DOC>NCT00828269</DOC>
	<brief_summary>The purpose of this study is to evaluate the quality of the RNA and the reproducibility of gene expression profiling from liver tissue samples obtained by fine needle aspiration.</brief_summary>
	<brief_title>Evaluation of RNA From the Liver Tissue Obtained in Patients With Chronic Hepatitis C (0000-123)</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis, Chronic</mesh_term>
	<mesh_term>Hepatitis C, Chronic</mesh_term>
	<criteria>Patient has chronic hepatitis C (Genotype 1) Patient has the ability to avoid use of anticoagulants, nonsteroidal antiinflammatory drugs and aspirin for at least 5 days before the liver biopsy Patient has received any approved or investigational drugs for the treatment of hepatitis C in the six months before the liver biopsy Patient has HIV or Hepatitis B virus Patient has been diagnosed with liver cancer Patient has evidence of cirrhosis on any previous liver biopsy Patient has confirmed alcohol abuse in the last 12 months Patient has participated in any investigational drug study within 90 days before the current study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Patients with Chronic Hepatitis C</keyword>
</DOC>